Search
Zoetis Inc
ZTSAdd to Watchlist
77.280USD
+1.250+1.64%
Close 07-31 16:00（ET）Quotes delayed by 15 min
32.48BMarket Cap
12.79P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Zoetis Inc is 7.71, ranking 96 out of 155 in the Pharmaceuticals industry. The average price target is 165.00, with a high of 200.00 and a low of 130.00.
Analyst Rating
Based on
20
analysts
Buy
Current Rating
105.951
Target Price
+35.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Zoetis Inc
ZTS
20
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Zoetis Inc's expected revenue for the next quarter?
Zoetis Inc's expected revenue is 2.50B.
What is Zoetis Inc's price target?
Analysts forecast that Zoetis Inc's price target is USD 165.00, with the highest forecast at USD 200.00 and the lowest forecast at USD 130.00.
How have Zoetis IncZTS's recent earnings per share performed?
The market expectation was USD 1.42, while Zoetis IncZTS's earnings per share (EPS) for the previous quarter was USD 1.38. EPS for the next quarter is expected at USD 1.86.
What is the analyst rating for Zoetis Inc?
Based on the ratings of Zoetis Inc's stock from 20 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.